menu
    • menu

    Company profile for Bio-Techne

    NEW Drugs in Dev: 1
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold ...
    Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bio-TechneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    614 McKinley Place NE Minneapolis, MN 55413
    Telephone
    Telephone
    612 379 2956
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bio-techne.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/bio-techne
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biotechne?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASCO GU

    ASCO GU

    Not Confirmed

    envelop Contact Supplier

    ASCO GU

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding
    Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding

    16 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-technes-ella-platform-achieves-ce-ivd-marking-expanding-access-to-rapid-cartridgebased-immunoassays-for-european-clinical-laboratories-302688454.html

    PR NEWSWIRE
    16 Feb 2026
    Share Share
    Bio-Techne Announces Changes to its Leadership Team
    Bio-Techne Announces Changes to its Leadership Team

    11 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-techne-announces-changes-to-its-leadership-team-302685129.html

    PR NEWSWIRE
    11 Feb 2026
    Share Share
    Bio-Techne Expands Stem Cell Portfolio With Synthetic Alternative
    Bio-Techne Expands Stem Cell Portfolio With Synthetic Alternative

    02 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-techne-expands-3d-stem-cell-and-organoid-culture-portfolio-with-a-fully-defined-synthetic-alternative-302675775.html

    PR NEWSWIRE
    02 Feb 2026
    Share Share
    Bio-Techne Introduces Ultra-Sensitive Neuro Biomarker Assays
    Bio-Techne Introduces Ultra-Sensitive Neuro Biomarker Assays

    28 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-techne-launches-simple-plex-ultra-sensitive-assays-on-ella-platform-to-enable-femtogram-level-detection-of-neurological-biomarkers-302672022.html

    PR NEWSWIRE
    28 Jan 2026
    Share Share
    Bio-Techne To Present At 2026 J.P. Morgan Health Conf
    Bio-Techne To Present At 2026 J.P. Morgan Health Conf

    23 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-2026-jp-morgan-healthcare-conference-302648108.html

    PR NEWSWIRE
    23 Dec 2025
    Share Share
    Bio-Techne To Present At Upcoming Investor Conferences
    Bio-Techne To Present At Upcoming Investor Conferences

    25 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302625027.html

    PR NEWSWIRE
    25 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search